UBS Global Life Sciences Conference, Day 3: Affymetrix, Exiqon | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Wednesday marked the last day of the UBS Global Life Sciences Conference where Affymetrix and Exiqon presented to investors.

Below are highlights from their talks.


Nearing three months into his return trip to Affymetrix, CEO Frank Witney continued to stress piggybacking on the next-generation sequencing market as a strategy to revive the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.